Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
International Immunopharmacology|August 24, 2021
Non-classical monocytes and its potential in diagnosing sepsis post cardiac surgeryAgnes Sebastian, S Sanju, Paresh Jain, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 9, 2021
Effect of genetics clinical decision support tools on health-care providers' decision making: a mixed-methods systematic reviewAgnes Sebastian, June C Carroll, Leslie E Oldfield, et al.
CMAJ Open|November 25, 2020
Use of real-world evidence in cancer drug funding decisions in Canada: a qualitative study of stakeholders' perspectivesMarc Clausen, Chloe Mighton, Ruhi Kiflen, et al.
Hospital Pediatrics|September 15, 2023
A Feeding Adequacy Scale for Children With Bronchiolitis: Prospective Multicenter StudyAgnes Sebastian, Cornelia M Borkhoff, Gita Wahi, et al.
European Journal of Medical Genetics|November 12, 2021
Challenges and practical solutions for managing secondary genomic findings in primary careAgnes Sebastian, June C Carroll, Meredith Vanstone, et al.
European Journal of Human Genetics : EJHG|March 29, 2021
Widening the lens of actionability: A qualitative study of primary care providers' views and experiences of managing secondary genomic findingsAgnes Sebastian, June C Carroll, Meredith Vanstone, et al.
Human Genetics|March 21, 2023
Great expectations: patients' preferences for clinically significant results from genomic sequencingSalma Shickh, Agnes Sebastian, Marc Clausen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 15, 2023
How do members of the public expect to use variants of uncertain significance in their health care? A population-based surveyChloe Mighton, Marc Clausen, Salma Shickh, et al.
Human Genetics|September 19, 2021
Patient and public preferences for being recontacted with updated genomic results: a mixed methods studyChloe Mighton, Marc Clausen, Agnes Sebastian, et al.
The Oncologist|April 6, 2022
"Game Changer": Health Professionals' Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome ManagementSalma Shickh, Leslie E Oldfield, Marc Clausen, et al.
Pageof 1